Avidity Biosciences, Inc. (RNA) Dividend History

Avidity Biosciences, Inc. is a biotechnology company focused on developing targeted RNA therapies using antibody-oligonucleotide conjugates. Their innovation aims to treat muscle and other diseases by delivering RNA-based therapeutics directly to specific tissues, leveraging their proprietary AOCs platform for precise and effective treatment options.

10578 Science Center Drive, San Diego, CA, 92121
Phone: 858-401-7900
Website: https://www.aviditybiosciences.com

Dividend History

Avidity Biosciences, Inc. currently does not pay dividends

Company News

Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows

June closed on a high note for the stock market, with the S&P 500, tracked by the SPDR S&P 500 ETF Trust (NYSE:SPY), gaining 3.2%, despite significant disparities in sector and industry performances. The technology sector, as tracked by the Technology Select Sector SPDR Fund (NYSE:XLK), led the 11 S&P 500 sectors in performance last month, surging 7.7% and achieving its strongest monthly gain this year. In stark contrast, utilities lagged, with the Utilities Select Sector SPDR Fund (NYSE:XLU) dropping 6.3%, marking the worst month since September 2023. Top Performing Industry ETFs In June The iShares Expanded Tech-Software Sector ETF (NYSE:IGV) rallied 11.3% last month, topping the rankings among industry ETFs. Hot on its heels was the VanEck Semiconductor ETF (NYSE:SMH), which climbed 8.4%, showcasing strong momentum in the semiconductor sector. Since hitting its low ...Full story available on Benzinga.com

Benzinga

Featured Companies: ADBE ALNY AVGO COPX CRWD IBB IGV OLED ORCL QRVO REZ SCLX SMH SOXX SPY XBI XLK XLU XSD
Avidity (RNA) Up 33% on Rare Muscle Disease Study Results

Initial data from an early-stage study shows that treatment with Avidity's (RNA) experimental therapy could address the underlying cause of a rare muscle-weakening condition.

Zacks Investment Research

Featured Companies: ARQT HRTX
2 Potentially High-Reward Growth Stocks to Buy Right Now

These two biotechnology stocks could be gearing up for a run.

The Motley Fool

Featured Companies: LRMR
The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks

A more selective small-cap index has consistently outperformed the Russell 2000

MarketWatch

Featured Companies: ACRV ALLO ARLO ATNM CMPX CPRX CRBU DGII DVAX GPRE HLX IJR INZY IPSC IRWD IWM KPTI LCTX LGND MODV PAYO PCRX PRVA PTEN RCUS RLYB SMTC SPY STOK TALO THRY TNYA TRVI VIGL VIR VOR XFOR XNCR XPER

Page data last updated 07/22/2025 23:28:06 UTC